Table 4.

Genetic testing outcomes∗.

Genetic testing results (N=125 )	N (75.0%)
Genetic testing completed	N=123 (98.4%)
Positive BRCA 1 or BRCA 2	18 (14.6 %)
Negative BRCA 1 or BRCA 2	17 (13.8%)
Negative NGS panel (including BRCA1/2)	52 (42.3 %)
Positive non-BRCA gene on NGS panel∗∗	8 (6.5 %)
VUS – BRCA1 or BRCA2	9 (7.3 %)
VUS other∗∗∗	21 (17.1 %)
Genetic testing pending	2 (1.6 %)

NGS: next generation sequencing; VUS: variant of uncertain significance.

 ^∗125 patients had undergone genetic testing during January 2015–December 2017. Results of the genetic tests were known for 123 patients, while results were pending for 2 patients.

 ^∗∗Non-BRCA pathogenic variants detected: BRIP1, MUTYH heterozygote, PALB2, RAD51C, and TP53(mos).

 ^∗∗∗Some patients had more than one VUS in multiple genes.